• HCM: The Key Role of Shared Decision-Making
    Feb 17 2026

    Utilizing shared decision-making in the diagnosis and management of hypertrophic cardiomyopathy can support positive outcomes for patients, family members and caregivers. Guests Kim Hecker, BSN, BA, RN, and Jillian Thorne, describe the process, and the impacts across all stages of the patient journey.


    References and related resources:


    2024 AHA/ACC Guideline for the Management of HCM


    Twice the Heart Foundation: https://www.instagram.com/twicetheheartfoundation/


    PCNA resources on HCM for providers and patients

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    18 Min.
  • LDL-C and Diabetes: Patient-Centered Strategies to Improve Outcomes
    Feb 3 2026

    Review the latest clinical guidelines on LDL-C reduction, especially for your patients with diabetes. Guest Susan Halli Demeter, DNP, CNP, NP, also reflects on how engaging patients in shared decision-making aids in treatment adherence and identifies potential barriers to address, including polypharmacy, access, and other issues.


    References and Related Resources:

    PCNA Lipid resources for providers and patients


    PCNA Diabetes resources for providers and patients


    CARDS trial

    IMPROVE-IT trial

    FOURIER trial

    ODYSSEY trial

    VESALIUS-CV trial


    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    19 Min.
  • LDL-C and Diabetes: Primary and Secondary Prevention Strategies in Diabetes
    Feb 3 2026

    Earlier ASCVD risk reduction is better--particularly for patients with diabetes. Guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, discusses the importance of reviewing family history, and shares strategies for decision-making in primary and secondary risk reduction strategies asuch as lowering LDL-C, blood glucose, hypertension, smoking, and other factors.


    Related Resources:


    PCNA Lipid resources for providers and patients


    PCNA Diabetes resources for providers and patients


    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease


    PREVENT Risk Calculator


    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    18 Min.
  • The Overlooked Link Between LDL-C and Diabetes
    Feb 3 2026

    What can we be doing to reduce LDL-C to decrease the risk for cardiovascular disease, particularly in our patients with diabetes? Learn from Margo B. Minissian, PhD, RN, ACNP-BC, NEA-BC, FAAN about the role of high blood sugar in cardiovascular disease, effective strategies for lowering LDL-C, and the importance of early treatment.


    Related Resources:


    PCNA Lipid Resources for Providers and Patients


    PCNA Diabetes Resources for Providers and Patients


    2018 AHA/ACC Guideline on the Management of Blood Cholesterol


    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease


    IVUS Regression Trials: REVERSAL (2004), ASTEROID (2006); SATURN (2011); GLAGOV (2016); PRECISE-IVUS(2015); JAPAN-ACS (2009)


    COURAGE trial


    VESALIUS-CV trial


    Pleiotropic effects of statins




    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    22 Min.
  • HCM: Signs, Symptoms, and Shared Decision-Making
    Jan 27 2026

    Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the US. Guest James Norton, BSN, RN, shares the hallmark signs and symptoms, and describes how shared decision-making in the care of patients with HCM from diverse populations.


    Related resources:

    AHA HCM sudden cardiac death risk calculator: https://professional.heart.org/en/guidelines-and-statements/hcm-risk-calculator


    Clinical Course & Management of HCM: https://www.nejm.org/doi/full/10.1056/NEJMra1710575


    HCM Sudden Cardiac Death Calculator: https://professional.heart.org/en/guidelines-and-statements/hcm-risk-calculator


    2024 AHA/ACC Guideline for the Management of HCM: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250


    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    18 Min.
  • Improving CV Outcomes for Black Women
    Jan 6 2026

    Guest Keri Barron, PhD, RN, CNE, shares ideas for improving cardiovascular outcomes for Black women. This includes individual actions such as preparation for clinical encounters and self-advocacy, as well as larger-scale initiatives like research and community outreach.


    Resources & References:


    PCNA articles:

    Faith-Based Cardiovascular Health. https://pcna.net/news/faith-based-cardiovascular-health/


    Understanding the Essentials: Cardiovascular Nurses in Community Outreach. https://pcna.net/news/understanding-the-essentials-cardiovascular-nurses-in-community-outreach/


    Cushman M, Shay CM, Howard VJ, et al. G10-Year Differences in Women's Awareness Related to Coronary Heart Disease. Circulation.2020. DOI: 10.1161/CIR.0000000000000907.

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    16 Min.
  • Cardiomyopathy: Clinical Trials and Patient Support
    Dec 30 2025

    Patients with cardiomyopathy may benefit from virtual patient support groups. Guest Andrea Linder, RN, MSN, CCRC, FPCNA, describes a successful model, with sessions that include both information and opportunities to share their questions and experiences. Andrea also discusses recent clinical trials and the impact of mavacamten on disease management.


    Related PCNA Resources:


    Patient Education Tool on Hypertrophic Cardiomyopathy: https://pcna.net/resource/hypertrophic-cardiomyopathy-what-you-need-to-know-fact-sheet/


    HCP tool on Hypertrophic Cardiomyopathy: https://pcna.net/resource/hypertrophic-cardiomyopathy-what-healthcare-providers-need-to-know/

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    11 Min.
  • Cardiovascular-Kidney-Metabolic Sydrome: Reducing Risk Through Screening and Early Intervention
    Dec 16 2025

    Cardiovascular-Kidney-Metabolic (CKM) Syndrome leads to poor health outcomes, and is affecting individuals at younger and younger ages. The PREVENT calculator helps identify individuals earlier in the disease progression, allowing time for intervientions that may lead to a regression on the stages of CKM. Guest Chiadi Ndumele, MD, PhD. also describes shared decision-making, and value- and volume-based care models.


    PREVENT calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator


    Pooled 10-year ASCVD Risk Calculator: https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/


    2025 Hypertension Guidelines Update: https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure/high-bp-top-10


    AHA CKM Scientific Statement: https://professional.heart.org/en/science-news/cardiovascular-kidney-metabolic-health-a-presidential-advisory


    PCNA CKM Resource list: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Mehr anzeigen Weniger anzeigen
    26 Min.